The relationship between ceramide profile and residual inflammatory risk in patients with coronary artery disease: Insights from an prospective study

Although progress has been made in managing cholesterol, targeting inflammation is essential for further reducing cardiovascular risk, as CVDs remain the leading cause of death globally. This study aimed to explore the association between plasma ceramide levels and residual inflammatory risk in patients with CAD.